Literature DB >> 10951419

Cutaneous angiosarcoma in an irradiated breast after breast conservation therapy for cancer: association with chronic breast lymphedema.

J Majeski1, R M Austin, R H Fitzgerald.   

Abstract

The authors report a rare case of cutaneous angiosarcoma arising more than 5 years after excision of a 1.5 cm invasive ductal cancer of the breast. All lymph nodes were negative for metastatic breast cancer in this 68-year-old female. The patient had postoperative therapy consisting of 5040 cGy over a 5 week period using a 6 Megavolt linear accelerator. After radiation therapy to the breast and axillae, the patient developed chronic hard, taut edema of the irradiated right breast. Tamoxifen was administered for 5 years and then stopped. Three months after the cessation of tamoxifen, cutaneous angiosarcoma was found by skin biopsy. A complete mastectomy removed all tumor with clear margins. There are less than 60 cases of radiation associated breast angiosarcoma found in the literature. The presence of chronic lymphedema in the breast after radiation therapy possibly contributes to the development and is an early warning sign for later development of secondary angiosarcoma. The characteristic purple nodules and discoloration of the irradiated skin is the hallmark to suspect the diagnosis. The authors recommend long-term clinical surveillance for this tumor for all patients who have received breast conservative surgical therapy with concomitant radiation therapy for primary breast cancer.

Entities:  

Mesh:

Year:  2000        PMID: 10951419     DOI: 10.1002/1096-9098(200007)74:3<208::aid-jso10>3.0.co;2-2

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  7 in total

1.  Angiosarcoma of the breast. Two cases following breast conserving treatment for invasive carcinoma.

Authors:  A Fernández Ortega; J M Gil Gil; A Urruticoetxea; J M Serra Payró
Journal:  Clin Transl Oncol       Date:  2006-07       Impact factor: 3.405

Review 2.  [Hemangiosarcoma after breast-conserving therapy of breast cancer: report of four cases with molecular genetic diagnosis and literature review].

Authors:  Carolin Nestle-Krämling; Edwin Bölke; Wilfried Budach; Matthias Peiper; Dieter Niederacher; Wolfgang Janni; Claus Ferdinand Eisenberger; Wolfram Trudo Knoefel; Axel Scherer; Stephan Ernst Baldus; Guido Lammering; Peter Arne Gerber; Christiane Matuschek
Journal:  Strahlenther Onkol       Date:  2011-08-16       Impact factor: 3.621

3.  Long-term outcomes in patients with radiation-associated angiosarcomas of the breast following surgery and radiotherapy for breast cancer.

Authors:  Keila E Torres; Vinod Ravi; Katherine Kin; Min Yi; B Ashleigh Guadagnolo; Caitlin D May; Banu K Arun; Kelly K Hunt; Ryan Lam; Guy Lahat; Aviad Hoffman; Janice N Cormier; Barry W Feig; Alexander J Lazar; Dina Lev; Raphael E Pollock
Journal:  Ann Surg Oncol       Date:  2012-12-06       Impact factor: 5.344

4.  A breast surgeon's paranoia pays off: the importance of keen clinical acumen in a case of postradiotherapy breast angiosarcoma.

Authors:  Adeel Zafar; Peter Neary; Gerrard O'Donoghue; Constantino Fiuza-Castinieria
Journal:  BMJ Case Rep       Date:  2012-08-18

5.  Radiation-induced sarcoma of the breast: a systematic review.

Authors:  Grishma R Sheth; Lee D Cranmer; Benjamin D Smith; Lauren Grasso-Lebeau; Julie E Lang
Journal:  Oncologist       Date:  2012-02-14

6.  Multiple cutaneous angiosarcomas after breast conserving surgery and bilateral adjuvant radiotherapy: an unusual case and review of the literature.

Authors:  Icro Meattini; Raffaella Santi; Daniele Scartoni; Irene Giacomelli; Carla De Luca Cardillo; Vieri Scotti; Donato Casella; Roberta Simoncini; Lorenzo Orzalesi; Jacopo Nori; Milena Paglierani; Lorenzo Livi
Journal:  Case Rep Oncol Med       Date:  2014-03-05

Review 7.  Radiogenic angiosarcoma of the breast: case report and systematic review of the literature.

Authors:  Askin Dogan; Peter Kern; Beate Schultheis; Günther Häusler; Günther A Rezniczek; Clemens B Tempfer
Journal:  BMC Cancer       Date:  2018-04-24       Impact factor: 4.430

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.